Nicholas K. Campbell
Profile
Nicholas K.
Campbell currently works at Achaogen, Inc., as Chief Restructuring Officer from 2019.
Former positions of Nicholas K. Campbell
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Nicholas K. Campbell
